ZA925515B - A process for the preparation of demethylepypodophyllotoxin - Google Patents

A process for the preparation of demethylepypodophyllotoxin

Info

Publication number
ZA925515B
ZA925515B ZA925515A ZA925515A ZA925515B ZA 925515 B ZA925515 B ZA 925515B ZA 925515 A ZA925515 A ZA 925515A ZA 925515 A ZA925515 A ZA 925515A ZA 925515 B ZA925515 B ZA 925515B
Authority
ZA
South Africa
Prior art keywords
demethylepipodophyllotoxin
beta
alkylidene
react
ester
Prior art date
Application number
ZA925515A
Other languages
English (en)
Inventor
Pietro Allevi
Allevi Pietro
Mario Anastasia
Anastasia Mario
Ettore Bigatti
Bigatti Ettore
Peter Macdonald
Macdonald Peter
Original Assignee
Sicor Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11360401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA925515(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sicor Spa filed Critical Sicor Spa
Publication of ZA925515B publication Critical patent/ZA925515B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA925515A 1991-07-23 1992-07-22 A process for the preparation of demethylepypodophyllotoxin ZA925515B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912025A IT1250692B (it) 1991-07-23 1991-07-23 Procedimento per la preparazione di demetilepipodofillotossina- beta-d-glucosidi.

Publications (1)

Publication Number Publication Date
ZA925515B true ZA925515B (en) 1993-04-28

Family

ID=11360401

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA925515A ZA925515B (en) 1991-07-23 1992-07-22 A process for the preparation of demethylepypodophyllotoxin

Country Status (16)

Country Link
US (1) US5688925A (de)
EP (1) EP0595888B1 (de)
JP (1) JP3231765B2 (de)
AT (1) ATE159026T1 (de)
AU (1) AU666322B2 (de)
CA (1) CA2113894C (de)
DE (1) DE69222643T2 (de)
DK (1) DK0595888T3 (de)
ES (1) ES2107546T3 (de)
FI (1) FI110782B (de)
GR (1) GR3025729T3 (de)
IL (1) IL102610A (de)
IT (1) IT1250692B (de)
MX (1) MX9204334A (de)
WO (1) WO1993002094A1 (de)
ZA (1) ZA925515B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119749A (en) * 1995-12-04 2001-03-19 Nippon Kayaku Kk Process for producing etoposide
JP4698775B2 (ja) * 1997-06-02 2011-06-08 ブリストル−マイヤーズ スクイブ カンパニー エトポシドの製造方法
WO2000015647A2 (en) * 1998-09-10 2000-03-23 Phytogen Life Sciences Inc. Synthetic method for the preparation of the antineoplastic agent etoposide
FR2791681B1 (fr) * 1999-03-29 2001-06-22 Pf Medicament Nouveau procede de preparation de l'etoposide
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
CN101146532B (zh) 2005-01-21 2012-05-09 阿斯泰克斯治疗有限公司 药物化合物
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
KR102090740B1 (ko) 2011-10-03 2020-03-18 엠엑스 아쥬바크 에이비 암 치료 및 식품 관련 화합물을 포함하는 의학 분야에서 양친매성 또는 소수성 분자를 위한 나노입자, 제조 방법 및 담체로의 용도
US9907846B2 (en) 2013-04-01 2018-03-06 Mx Adjuvac Ab Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
EP3616688A1 (de) 2018-08-27 2020-03-04 Centre National de la Recherche Scientifique - CNRS Herstellung von nanosuspensionshaltigen nanokristallen von pharmazeutischen wirkstoffen mit geringen oder keinen stabilisatoren
EP3669890A1 (de) 2018-12-18 2020-06-24 Croda International PLC Filamentöse nanopartikel mit impfstoffadjuvanswirkung
CN113121618A (zh) * 2021-04-07 2021-07-16 梯尔希(南京)药物研发有限公司 两种依托泊苷杂质的制备方法
CN115197281B (zh) * 2021-04-09 2024-06-14 四川汇宇制药股份有限公司 依托泊苷中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111058B1 (de) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Verfahren zur Herstellung von 4'-Demethyl-epipodophylotoxin-beta-D-ethyliden-glucosid und Acylderivate davon
JPS60246393A (ja) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd エトポシドの新規製造法
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
DK39886D0 (da) * 1986-01-27 1986-01-27 Hans Goeran Magnusson Hydroxybeskyttelsesgrupper
US4904768A (en) * 1987-08-04 1990-02-27 Bristol-Myers Company Epipodophyllotoxin glucoside 4'-phosphate derivatives
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
DE3935016A1 (de) * 1989-10-20 1991-04-25 Behringwerke Ag Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten
FR2658824B1 (fr) * 1990-02-27 1992-07-03 Pf Medicament Tris acetyl-2",3",4' ethylidene-4",6" beta-d-glucopyranosides, leur preparation et leur utilisation pour la preparation d'ethylidene beta-d-glucopyranoside de demethyl-4' epipodophyllotoxine.
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
CN1025918C (zh) * 1990-06-07 1994-09-14 国家医药管理局上海医药工业研究院 抗肿瘤药表鬼臼毒吡喃糖甙的合成新工艺

Also Published As

Publication number Publication date
GR3025729T3 (en) 1998-03-31
FI940280A (fi) 1994-01-20
AU666322B2 (en) 1996-02-08
WO1993002094A1 (en) 1993-02-04
AU2326592A (en) 1993-02-23
CA2113894A1 (en) 1993-02-04
JP3231765B2 (ja) 2001-11-26
CA2113894C (en) 2003-12-16
DE69222643T2 (de) 1998-02-05
EP0595888B1 (de) 1997-10-08
ITMI912025A0 (it) 1991-07-23
FI940280A0 (fi) 1994-01-20
DK0595888T3 (da) 1998-05-18
ITMI912025A1 (it) 1993-01-24
ATE159026T1 (de) 1997-10-15
IL102610A (en) 1997-03-18
DE69222643D1 (de) 1997-11-13
IT1250692B (it) 1995-04-21
EP0595888A1 (de) 1994-05-11
ES2107546T3 (es) 1997-12-01
US5688925A (en) 1997-11-18
JPH06509334A (ja) 1994-10-20
FI110782B (fi) 2003-03-31
MX9204334A (es) 1993-02-01

Similar Documents

Publication Publication Date Title
GR3025729T3 (en) A process for the preparation of demethylepypodophyllotoxin
HUT60328A (en) Process for producing ethanol with transformed microorganisms
EP0411897A3 (en) Avermectin derivatives
MX9704765A (es) Mejoras en o que se relacionan con la funcion endometrial.
AU628546B2 (en) Energy meter
AU6772790A (en) Monodisperse hexagonal boron nitride with a very high putity level with respect to metals and oxygen and its preparation process
AU4782790A (en) Novel tetralin derivatives
AU1844688A (en) Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
EP0246646A3 (en) Process for the preparation of 4-acetals of 1,4-butene dial, and acetals of 1,4-butene dial
DE3663257D1 (en) Antihelmintic avermectin derivatives produced by the fermentation of a microorganism
IL93592A0 (en) Mammalian cell line and its use for detecting certain molecules
GB2162193B (en) Reactive dyes, process for their preparation and use thereof
IE883358L (en) Ethylated avermectins
AU5881386A (en) Cell discriminating fluorescent 3,17 substituted estradiols
AU631935B2 (en) Triphenodioxane reactive dyes
EP0297044A3 (en) Reactive dyes, process for their preparation and their use
DE3160133D1 (en) 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines, process for their preparation and pharmaceutical compositions containing them
KR890000156B1 (en) Hydantoin derivatives
GB8620785D0 (en) Microorganism culture & testing
岩元睦夫 Non-destructive analysis
GB8917496D0 (en) Microbiological production of 2,3-epoxypropyl ethers
Stosic et al. Effect of photoperiod on the calcium uptake by microsomes and mitochondria from green leaves
EP0257276A3 (de) Verfahren zur Herstellung von Antibiotikum LL-42067alpha
GB8819758D0 (en) Production of 2-methyl-5-isopropyl-hexa-2,5-dien-1-al & of 2-methyl-5-isopropyl-hexa-2,4-dien-1-al in microorganisms
JPS57126499A (en) 4'-deoxymycaminosyl tylonoline derivative